Ginkgo Bioworks (DNA) Registers Modest Insider Sale via Form 144

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc. (DNA) filed a Form 144 disclosing a planned disposition of 2,200 Class A shares (estimated value $31,020) through Fidelity Brokerage beginning on 08/06/2025. The shares, acquired via restricted-stock vesting on 10/17/2022, equal roughly 0.005% of the reported 46.34 million shares outstanding—an immaterial portion of DNA’s float.

The account holder, Austin Che, has already sold small 99-share lots over the last three months, totaling 3,366 shares for about $27 k plus a 2,200-share block on 07/09/2025 for $24.6 k. Form 144 requires the filer to certify no possession of undisclosed material information and, if relying on Rule 10b5-1, that a compliant trading plan exists. No operational, earnings, or strategic data accompany the notice; it solely signals modest insider liquidity. Given the limited size, analysts should expect negligible impact on DNA’s share supply or valuation.

Positive

• None.

Negative

• Ongoing insider selling, albeit small, could slightly dampen investor sentiment if viewed as lack of confidence.

Insights

Securities Analyst

TL;DR: 2,200-share Form 144 adds to recent small insider sales; size trivial, market impact minimal, sentiment marginally negative.

The filing shows another incremental sale by insider Austin Che, bringing three-month disclosed sales to roughly 5,566 shares. At today’s price, gross proceeds remain well below $100 k, dwarfed by DNA’s multi-billion-share float. Such activity is typical liquidity, not an outright exit, and aligns with shares received via compensation. No new information on fundamentals or guidance is provided. While serial insider selling can weigh on investor sentiment, the microscopic percentage sold and transparent Rule 144 notice render the event neutral from a valuation standpoint.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2200	31020.00	46344630	08/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/17/2022	Restricted Stock Vesting	Issuer			2200	10/17/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/06/2025	99	668.25
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/07/2025	99	676.17
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/08/2025	99	741.51
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/09/2025	99	789.03
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/12/2025	99	807.84
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/13/2025	99	831.60
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/14/2025	99	792.99
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/15/2025	99	765.27
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/16/2025	99	764.28
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/19/2025	99	762.30
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/20/2025	99	801.90
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/21/2025	99	778.14
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/22/2025	99	707.85
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/23/2025	99	668.25
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/27/2025	99	712.80
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/28/2025	99	689.04
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/29/2025	99	754.38
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/30/2025	99	704.88
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/02/2025	99	690.03
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/03/2025	99	719.73
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/04/2025	99	747.45
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/05/2025	99	752.40
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/06/2025	99	724.68
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/09/2025	99	767.25
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/10/2025	99	791.01
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/11/2025	99	884.07
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/12/2025	99	941.49
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/13/2025	99	883.08
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/16/2025	99	894.96
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/17/2025	99	896.94
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/18/2025	99	837.54
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/20/2025	99	857.34
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/23/2025	99	834.57
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	07/09/2025	2200	24596.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Ginkgo Bioworks (DNA) shares are being registered for sale?

The Form 144 covers 2,200 Class A shares, valued at roughly $31,020.

Who is the insider selling DNA shares and when were they acquired?

The proposed seller is Austin Che; the shares vested as restricted stock on 10/17/2022.

When is the expected sale date for the DNA shares?

The filing lists an approximate sale date of 08/06/2025.

What percentage of DNA’s outstanding shares does the sale represent?

The 2,200 shares equal about 0.005 % of the reported 46.34 million shares outstanding.

Is the seller relying on a Rule 10b5-1 trading plan?

The form allows reliance on Rule 10b5-1; by signing, the seller certifies any such plan complies, though no specific date was disclosed.

Have there been other recent insider sales at Ginkgo Bioworks?

Yes. Over the past three months, Che disclosed multiple 99-share trades totaling 3,366 shares plus a 2,200-share block on 07/09/2025.